The design and synthesis of novel inhibitors of NADH:ubiquinone oxidoreductase
摘要:
Potent new inhibitors of NADH:ubiquinone oxidoreductase (complex 1) have been designed, with the help of molecular modelling, by hybridisation of known complex I inhibitors with inhibitors of cytochrome c oxidoreductase. The most interesting compound was the chromone 7 which was a selective inhibitor of complex I (IC50 15 nM) and showed acaricidal activity against spider mites. (C) 2003 Elsevier Ltd. All rights reserved.
The design and synthesis of novel inhibitors of NADH:ubiquinone oxidoreductase
摘要:
Potent new inhibitors of NADH:ubiquinone oxidoreductase (complex 1) have been designed, with the help of molecular modelling, by hybridisation of known complex I inhibitors with inhibitors of cytochrome c oxidoreductase. The most interesting compound was the chromone 7 which was a selective inhibitor of complex I (IC50 15 nM) and showed acaricidal activity against spider mites. (C) 2003 Elsevier Ltd. All rights reserved.
The present disclosure is directed, in part, to compounds and methods for imaging myocardial perfusion, comprising administering to a patient a contrast agent which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging.
The design and synthesis of novel inhibitors of NADH:ubiquinone oxidoreductase
作者:Stephen D. Lindell、Oswald Ort、Peter Lümmen、Robert Klein
DOI:10.1016/j.bmcl.2003.10.022
日期:2004.1
Potent new inhibitors of NADH:ubiquinone oxidoreductase (complex 1) have been designed, with the help of molecular modelling, by hybridisation of known complex I inhibitors with inhibitors of cytochrome c oxidoreductase. The most interesting compound was the chromone 7 which was a selective inhibitor of complex I (IC50 15 nM) and showed acaricidal activity against spider mites. (C) 2003 Elsevier Ltd. All rights reserved.